Speakers

Anthony White obtained a PhD in neuroscience from Murdoch University in 1996, then undertook a post-doctoral position at University of Melbourne investigating Alzheimer’s and prion diseases. He worked at Imperial College of Medicine, UK, in 2001 studying immunotherapeutic approaches to prion diseases. He established a research group at the Department of Pathology, University of Melbourne investigating the role of biometals in neurodegeneration, and development of metal-based drugs for treatment of these disorders. He received an Australian Research Council Future Fellowship in 2011, was recruited to QIMR Berghofer in 2016, and was awarded a National Health and Medical Research Council Senior Research Fellowship in 2017. His research has contributed to the development of first-in-class metal-drugs as a potential new therapeutic approach to treat brain disorders. He is currently developing new human patient-based brain models and applying these to understanding the impacts of air pollution and bushfire smoke in brain health and disease. He is also overseeing studies that aim to extend the cell-based findings on bushfire smoke health impact to firefighters in the field, and the broader community.